number;Key;item_type;publication_year;author_et_al;Author;title;journal_title;ISBN;ISSN;DOI;Dimension - Final;Subcategory - Final;Date;Pages;Issue;Volume;journal_abbr;Fields;article_type;author_country;data_country;data_source;data_date;cohort_details;Diagnosis;Procedure;Laboratory;Patient Demographics;Observation;Scores;Medication;med_details;med_dose;study_registration;cohort_definition;cohort_link;study_protocol;study_protocol_link;sp_accecss_date
1;VJ45YNUQ;journalArticle;2021;Kim, Ha Il et al., 2021;"Kim, Ha Il; Yoon, Jin Young; Kwak, Min Seob; Cha, Jae Myung";Gastrointestinal and Nongastrointestinal Complications of Esophagogastroduodenoscopy and Colonoscopy in the Real World: A Nationwide Standard Cohort Using the Common  Data Model Database.;Gut and liver;;2005-1212 1976-2283;10.5009/gnl20222;usage;study;06.01.21;;;;Gut Liver;med;Journal Paper;South Korea;single-country;HIRA;2012 to 2017;" 30-day GI and non-GI complications in patients 
18 years or older undergoing outpatient EGD, colonoscopy, or colonoscopic polypectomy";yes;yes;no;>= 18 years (age);no;no;no;no;no;no;no;;no;;
2;2YKGPTYE;journalArticle;2021;Lane, Jennifer C. E. et al., 2021;"Lane, Jennifer C. E.; Weaver, James; Kostka, Kristin; Duarte-Salles, Talita; Abrahao, Maria Tereza F.; Alghoul, Heba; Alser, Osaid; Alshammari, Thamir M.; Areia, Carlos; Biedermann, Patricia; Banda, Juan M.; Burn, Edward; Casajust, Paula; Fister, Kristina; Hardin, Jill; Hester, Laura; Hripcsak, George; Kaas-Hansen, Benjamin Skov; Khosla, Sajan; Kolovos, Spyros; Lynch, Kristine E.; Makadia, Rupa; Mehta, Paras P.; Morales, Daniel R.; Morgan-Stewart, Henry; Mosseveld, Mees; Newby, Danielle; Nyberg, Fredrik; Ostropolets, Anna; Woong Park, Rae; Prats-Uribe, Albert; Rao, Gowtham A.; Reich, Christian; Rijnbeek, Peter; Sena, Anthony G.; Shoaibi, Azza; Spotnitz, Matthew; Vignesh, Subbian; Suchard, Marc A.; Vizcaya, David; Wen, Haini; de Wilde, Marcel; Xie, Junqing; You, Seng Chan; Zhang, Lin; Lovestone, Simon; Ryan, Patrick; Prieto-Alhambra, Daniel";Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.;Rheumatology (Oxford, England);;1462-0332 1462-0324;10.1093/rheumatology/keaa771;usage;study;25.12.20;;;;Rheumatology (Oxford);med;Journal Paper;UK;multi-country;CPRD, MRD, SIDIAP, DAGermany,IPCI, OptumEHR, AmbEMR, CCAE, Clinformatics, MDCR, MDCD, OpenClaims, JMDC ;01/09/2000 - latest available data in 2020;"Rheumatoid Arthritis, suplement files availabel 
with details";yes;yes;yes;>= 18 years (age);no;no;yes;"Sulfasalazine (concept_id = 964339), 
Hydroxychloroquine(concept_id = 1777087), Azithromycin(concept_id = 1734104), Amoxicillin (concept_id = 1713332)";no;https://www.encepp.eu/encepp/viewResource.htm?id=34498;yes;links available in supplement files;yes;https://www.encepp.eu/encepp/openAttachment/fullProtocolLatest/35592;23.01.23
3;JSMS49HL;journalArticle;2021;Morales, Daniel R. et al., 2021;"Morales, Daniel R.; Conover, Mitchell M.; You, Seng Chan; Pratt, Nicole; Kostka, Kristin; Duarte-Salles, Talita; Fern√°ndez-Bertol√≠n, Sergio; Arag√≥n, Maria; DuVall, Scott L.; Lynch, Kristine; Falconer, Thomas; van Bochove, Kees; Sung, Cynthia; Matheny, Michael E.; Lambert, Christophe G.; Nyberg, Fredrik; Alshammari, Thamir M.; Williams, Andrew E.; Park, Rae Woong; Weaver, James; Sena, Anthony G.; Schuemie, Martijn J.; Rijnbeek, Peter R.; Williams, Ross D.; Lane, Jennifer C. E.; Prats-Uribe, Albert; Zhang, Lin; Areia, Carlos; Krumholz, Harlan M.; Prieto-Alhambra, Daniel; Ryan, Patrick B.; Hripcsak, George; Suchard, Marc A.";Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.;The Lancet. Digital health;;2589-7500;10.1016/S2589-7500(20)30289-2;usage;study;2021-02;e98-e114;2;3;Lancet Digit Health;med;Journal Paper;UK;multi-country; CUIMC, VA, SIDIAP ;01/11/2019 - bis 31/01/2020;"ACE inhibitors, ARB (angiotensin 
II receptor blockers) on the risk of contracting COVID- 19 infection in hypertensive patients; on the risk of respiratory failure, pneumonia, acute kidney injury, and death in hypertensive patients diagnosed with COVID-19.";yes;no;no;>= 18 years (age);no;no;yes;"ACE inhibitors, ARB, leider so 
schnell keine concept ids oder ATC codes identifiziert";no;https://www.encepp.eu/encepp/viewResource.htm?id=35854;yes;;yes;https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf;23.01.23
4;WADW3J7V;journalArticle;2020;Burn, Edward et al., 2020b;"Burn, Edward; Sena, Anthony G.; Prats-Uribe, Albert; Spotnitz, Matthew; DuVall, Scott; Lynch, Kristine E.; Matheny, Michael E.; Nyberg, Fredrik; Ahmed, Waheed-Ul-Rahman; Alser, Osaid; Alghoul, Heba; Alshammari, Thamir; Zhang, Lin; Casajust, Paula; Areia, Carlos; Shah, Karishma; Reich, Christian; Blacketer, Clair; Andryc, Alan; Fortin, Stephen; Natarajan, Karthik; Gong, Mengchun; Golozar, Asieh; Morales, Daniel; Rijnbeek, Peter; Subbian, Vignesh; Roel, Elena; Recalde, Martina; Lane, Jennifer C. E.; Vizcaya, David; Posada, Jose D.; Shah, Nigam H.; Jonnagaddala, Jitendra; Hui Lai, Lana Yin; Avil√©s-Jurado, Francesc Xavier; Hripcsak, George; Suchard, Marc A.; Ranzani, Otavio T.; Ryan, Patrick; Prieto-Alhambra, Daniel; Kostka, Kristin; Duarte-Salles, Talita";Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 240,392 patients hospitalized with COVID-19 in the United States.;medRxiv : the preprint server for health sciences;;;10.1101/2020.11.25.20229088;usage;study;27.11.20;;;;medRxiv;med;PrePrint;US;single-country;HealthVerity, Premier, IQVIAHospital, VA OpenClaims, OptumEHR, ;"bis max. July 2020 - Startdatum 
nicht konkret benannt, aber mit Start von COVID-19 Pandemie";"COVID-19 Kohort Characterisierung mit Fokus auf 
die Prozeduren: Dialyse, Tracheostomy, ECMO";yes;yes;no;"keine Aussagen, Auswertung nur 
erfolgt mit <= und > 65 Jahren";no;no;no;no;no;no;yes;;yes, aber größer nämlich das CHARYBDIS Studienprotokoll, das verwendet nur die Basline Daten Information aus CHARYBDIS;https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis/tree/master/documents;
5;48384RBQ;journalArticle;2020;You, Seng Chan et al., 2020;"You, Seng Chan; Rho, Yeunsook; Bikdeli, Behnood; Kim, Jiwoo; Siapos, Anastasios; Weaver, James; Londhe, Ajit; Cho, Jaehyeong; Park, Jimyung; Schuemie, Martijn; Suchard, Marc A.; Madigan, David; Hripcsak, George; Gupta, Aakriti; Reich, Christian G.; Ryan, Patrick B.; Park, Rae Woong; Krumholz, Harlan M.";Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.;JAMA;;1538-3598 0098-7484;10.1001/jama.2020.16167;usage;study;27.10.20;1640-1650;16;324;JAMA;med;Journal Paper;South Korea;multi-country;IQVIAHospital, OptumEHR, HIRA;"11/2011 bis 03/2019
2013-03-01 to 2016-12-31 (drug   exposure)";Patienten mit Coronary Synsrome (ACS), Behandlung mit Percutaneous Coronary Intervention (PCI) - Frage nach besserem Ergebnis bei Ticagrelor oder Clopidogrel?;yes;yes;yes;>= 20 years;no;no;yes;"ticagrelor (OMOP concept_id =40241186,  RxNorm ingredient), clopidogrel (concept_id = 1322184, RxNorm ingredient), 
Medikationsdaten wurden auf erfasst 7 Tage vor Index Date - also PCI Eingriff

in der Analyse dann auch andere Medikamente noch dazu: Aspirin, Statins, Beta-Blocker, Calcium channel blockers, ACE inhibitors, Proton pump inhibitors, Diuretics, Angiotensin II antagonists, Insulins and analogues, Blood glucose-lowering drugs -  except insulins, Abciximab, Warfarin, Apixaban, Dabigatran, Rivaroxaban";no;no;yes;"Supplment 1
https://cdn.jamanetwork.com/ama/content_public/journal/jama/938576/joi200094supp1_prod_1603319690.62454.pdf?Expires=1677712133&Signature=Suh1MTrnVNEEl~MgV~s9mMiV56rYlPHFFhFCAaU1O1zWZiA2DR2QzLJ2BNpNt7qL8UagedIuuUeDya5Mtg55gEas3YOwLgNambsSUcHH6r457~vXLDzIc6IWuq5DE6v7OL4vVh8YVujkI6e1~6nWvqodEfccg5B2ru7wO-1GnfDsn74gwadH2wwpMvtVsevp0lt-hfG6AYGX7Je8IRXP-3gn6fMpANcxatfD7ywgEaGFozN3elKahLtt9fWWmAteMijyKc9cLv4MCHSjrhYjdSmfI1wNIsNFfjo0bGjOo-s3bCFZ23Etz3D1IstNzWKEjfGvtMkL2kb6vdM03ZSf0Q__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA";yes;"Supplement 2
https://cdn.jamanetwork.com/ama/content_public/journal/jama/938576/joi200094supp2_prod_1603319690.62454.pdf?Expires=1677712133&Signature=u0NWWPhoxoPM3pWqg~vkRQfgNSEmqcSSUWMh3lHsEqZ9J5vwX~xXiqfx03WWA8D8UvKLS1Gq5NALBhcCD315yf3OLRQaOHOP33MsG2Sh-tgYgLFmnXb07Se3h84v-zYoGBNhICcH8REpOveX-Y2PFkZRG-1hJCdz~Sj2Iq0hiTxluGGo3XgMGUqzlgBimArwBw5e~h-e41gtclX~ejxtVblo2xitWOqF-a0iwPlre1sL40X2NlQdThlOvLg6o3a9AXkrogRa0f3zBR-FpzqaFONpNO1bKtTbo1Zp7~GpUPQPihml2r93ozDm0byn6bbU8t4twnDNazJh4lUvRF6mDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA";23.01.23
6;MT8S2Y37;journalArticle;2020;Burn, Edward et al., 2020a;"Burn, Edward; You, Seng Chan; Sena, Anthony G.; Kostka, Kristin; Abedtash, Hamed; Abrah√£o, Maria Tereza F.; Alberga, Amanda; Alghoul, Heba; Alser, Osaid; Alshammari, Thamir M.; Aragon, Maria; Areia, Carlos; Banda, Juan M.; Cho, Jaehyeong; Culhane, Aedin C.; Davydov, Alexander; DeFalco, Frank J.; Duarte-Salles, Talita; DuVall, Scott; Falconer, Thomas; Fernandez-Bertolin, Sergio; Gao, Weihua; Golozar, Asieh; Hardin, Jill; Hripcsak, George; Huser, Vojtech; Jeon, Hokyun; Jing, Yonghua; Jung, Chi Young; Kaas-Hansen, Benjamin Skov; Kaduk, Denys; Kent, Seamus; Kim, Yeesuk; Kolovos, Spyros; Lane, Jennifer C. E.; Lee, Hyejin; Lynch, Kristine E.; Makadia, Rupa; Matheny, Michael E.; Mehta, Paras P.; Morales, Daniel R.; Natarajan, Karthik; Nyberg, Fredrik; Ostropolets, Anna; Park, Rae Woong; Park, Jimyung; Posada, Jose D.; Prats-Uribe, Albert; Rao, Gowtham; Reich, Christian; Rho, Yeunsook; Rijnbeek, Peter; Schilling, Lisa M.; Schuemie, Martijn; Shah, Nigam H.; Shoaibi, Azza; Song, Seokyoung; Spotnitz, Matthew; Suchard, Marc A.; Swerdel, Joel N.; Vizcaya, David; Volpe, Salvatore; Wen, Haini; Williams, Andrew E.; Yimer, Belay B.; Zhang, Lin; Zhuk, Oleg; Prieto-Alhambra, Daniel; Ryan, Patrick";Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.;Nature communications;;2041-1723;10.1038/s41467-020-18849-z;usage;study;06.10.20;5009;1;11;Nat Commun;med;Journal Paper;UK;multi-country;"

CUIMC: 1759; HIRA: 7341; HM: 2078; PHD: 5257; SIDIAP: 16,347; UC HDC: 769; VA: 577
Additional databases, analysis performed, but not reported in the paper: CLARET, STARR-OMOP, FEEDER-NET";eigentlich zw. 2009 und 04.2020;"es geht um den Vergleich der hospitalisierten 
COVID-19 Patienten mit denen an Influenza erkrankten, ebenfalls hospitalisiert";yes;no;no;>= 18 years (age);no;no;yes;"drug eras wurden kalkuliert, ATC Codes wurden verwendet;
Agents acting on the renin-angiotensin system
Antivirals for systemic use
Antidepressants
Antiepileptics
Antiinflammatory and antirheumatic products
Antineoplastic agents
Antipsoriatics
Antithrombotic agents
Beta blocking agents
Calcium channel blockers
Diuretics
Drugs for acid related disorders
Drugs for obstructive airway diseases
Drugs used in diabetes
Immunosuppressants
Lipid modifying agents";no;no;no;leider nicht unter source code referenz verfügbar:  https://github.com/ohdsi- studies/Covid19HospitalizationCharacterization;no;;23.01.23
7;C8VXZHVQ;journalArticle;2020;Lane, Jennifer C.E. et al., 2020;"Lane, Jennifer C. E.; Weaver, James; Kostka, Kristin; Duarte-Salles, Talita; Abrahao, Maria Tereza F.; Alghoul, Heba; Alser, Osaid; Alshammari, Thamir M.; Biedermann, Patricia; Banda, Juan M.; Burn, Edward; Casajust, Paula; Conover, Mitchell M.; Culhane, Aedin C.; Davydov, Alexander; DuVall, Scott L.; Dymshyts, Dmitry; Fernandez-Bertolin, Sergio; Fi≈°ter, Kristina; Hardin, Jill; Hester, Laura; Hripcsak, George; Kaas-Hansen, Benjamin Skov; Kent, Seamus; Khosla, Sajan; Kolovos, Spyros; Lambert, Christophe G.; van der Lei, Johan; Lynch, Kristine E.; Makadia, Rupa; Margulis, Andrea V.; Matheny, Michael E.; Mehta, Paras; Morales, Daniel R.; Morgan-Stewart, Henry; Mosseveld, Mees; Newby, Danielle; Nyberg, Fredrik; Ostropolets, Anna; Park, Rae Woong; Prats-Uribe, Albert; Rao, Gowtham A.; Reich, Christian; Reps, Jenna; Rijnbeek, Peter; Sathappan, Selva Muthu Kumaran; Schuemie, Martijn; Seager, Sarah; Sena, Anthony G.; Shoaibi, Azza; Spotnitz, Matthew; Suchard, Marc A.; Torre, Carmen O.; Vizcaya, David; Wen, Haini; de Wilde, Marcel; Xie, Junqing; You, Seng Chan; Zhang, Lin; Zhuk, Oleg; Ryan, Patrick; Prieto-Alhambra, Daniel";Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.;The Lancet Rheumatology;;2665-9913;10.1016/S2665-9913(20)30276-9;usage;study;2020-11;e698-e711;11;2;Lancet Rheumatol;med;Journal Paper;UK,US;multi-country;VA, DAGermany, IMRD AmbEMR, OpenClaims, CPRD, CCAE, MDCD, MDCR, IPCI, JMDC, Clinformatics, OptumEHR, SIDIAP;01.09.2000 bis letztes verfügbares Datum 2020 in den Datenquellen;"Hydroxychloroquine, a drug commonly used in the 
treatment of rheumatoid arthritis, has received much negative publicity for adverse events associated with its authorisation for emergency use to treat patients with COVID-19 pneumonia. We studied the safety of hydroxychloroquine, alone and in combination with azithromycin, to determine the risk associated with its use in routine care in patients with rheumatoid arthritis.";yes;no;no;>= 18 years (age);yes;yes;yes;"Hydroxychloroquine, 
sulfasalazine, Azithromycin, Amoxicillin ()RxNorm ingredient, ATC)";no;no;yes;https://www.thelancet.com/cms/10.1016/S2665-9913(20)30276-9/attachment/ea3b2efd-6ac0-4f3e-8864-8451ffbb3253/mmc1.pdf;yes;https://www.thelancet.com/cms/10.1016/S2665-9913(20)30276-9/attachment/ea3b2efd-6ac0-4f3e-8864-8451ffbb3253/mmc1.pdf;
8;XDZG64ZW;journalArticle;2020;Brat, Gabriel A. et al., 2020;"Brat, Gabriel A.; Weber, Griffin M.; Gehlenborg, Nils; Avillach, Paul; Palmer, Nathan P.; Chiovato, Luca; Cimino, James; Waitman, Lemuel R.; Omenn, Gilbert S.; Malovini, Alberto; Moore, Jason H.; Beaulieu-Jones, Brett K.; Tibollo, Valentina; Murphy, Shawn N.; Yi, Sehi L'; Keller, Mark S.; Bellazzi, Riccardo; Hanauer, David A.; Serret-Larmande, Arnaud; Gutierrez-Sacristan, Alba; Holmes, John J.; Bell, Douglas S.; Mandl, Kenneth D.; Follett, Robert W.; Klann, Jeffrey G.; Murad, Douglas A.; Scudeller, Luigia; Bucalo, Mauro; Kirchoff, Katie; Craig, Jean; Obeid, Jihad; Jouhet, Vianney; Griffier, Romain; Cossin, Sebastien; Moal, Bertrand; Patel, Lav P.; Bellasi, Antonio; Prokosch, Hans U.; Kraska, Detlef; Sliz, Piotr; Tan, Amelia L. M.; Ngiam, Kee Yuan; Zambelli, Alberto; Mowery, Danielle L.; Schiver, Emily; Devkota, Batsal; Bradford, Robert L.; Daniar, Mohamad; Daniel, Christel; Benoit, Vincent; Bey, Romain; Paris, Nicolas; Serre, Patricia; Orlova, Nina; Dubiel, Julien; Hilka, Martin; Jannot, Anne Sophie; Breant, Stephane; Leblanc, Judith; Griffon, Nicolas; Burgun, Anita; Bernaux, Melodie; Sandrin, Arnaud; Salamanca, Elisa; Cormont, Sylvie; Ganslandt, Thomas; Gradinger, Tobias; Champ, Julien; Boeker, Martin; Martel, Patricia; Esteve, Loic; Gramfort, Alexandre; Grisel, Olivier; Leprovost, Damien; Moreau, Thomas; Varoquaux, Gael; Vie, Jill-J√™nn; Wassermann, Demian; Mensch, Arthur; Caucheteux, Charlotte; Haverkamp, Christian; Lemaitre, Guillaume; Bosari, Silvano; Krantz, Ian D.; South, Andrew; Cai, Tianxi; Kohane, Isaac S.";International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium.;NPJ digital medicine;;2398-6352;10.1038/s41746-020-00308-0;usage;study;19.08.20;109;1;3;NPJ Digit Med;mi;Journal Paper;US;multi-country;"4CE - Consortium in 5 Countries, hospital based per country
US
Singapore
Italy
France
Germany - i2b2 data (inpatient, Erlangen, Mannheim, Freiburg)";January 1, 2020 through April 11, 2020;Cohort, 27584 patients included, laboratory check;yes;no;yes;ageno;no;no;no;;no;no;no, in paper only;no;no;no;
9;EAPELT3A;journalArticle;2020;Kim, Yeesuk et al., 2020;"Kim, Yeesuk; Tian, Yuxi; Yang, Jianxiao; Huser, Vojtech; Jin, Peng; Lambert, Christophe G.; Park, Hojun; You, Seng Chan; Park, Rae Woong; Rijnbeek, Peter R.; Van Zandt, Mui; Reich, Christian; Vashisht, Rohit; Wu, Yonghui; Duke, Jon; Hripcsak, George; Madigan, David; Shah, Nigam H.; Ryan, Patrick B.; Schuemie, Martijn J.; Suchard, Marc A.";Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis.;Scientific reports;;2045-2322;10.1038/s41598-020-68037-8;usage;study;06.07.20;11115;1;10;Sci Rep;med;Journal Paper;South Korea;multi-country;UTCHF, CUIMC, STARR-OMOP,  Clinformatics Datamart , CCAE, MDCD, MDCR, P-Plus, HIRA;mehr 300 Mio patientendaten;Frauen mit Osteoporose, verleich von Medikamentenwirksamkeit von Alendronate und raloxifene, es geht dabei um Neue Nutzerinnen von den Medikamenten, Comperative Study in OMOP;yes;yes;no;> 45 years, women only;no;no;yes;alendronate (concept_id = 1557272, RxNorm), raloxifene (concept_id = 1513103, RxNorm), bazedoxifene (concept_id = 44506794, RxNorm), Bisphosphonates = (concept_id = 21604148, ATC!´);no;no;yes;https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-020-68037-8/MediaObjects/41598_2020_68037_MOESM1_ESM.pdf;yes;https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-020-68037-8/MediaObjects/41598_2020_68037_MOESM1_ESM.pdf;29.01.23
10;M57ZKJDG;journalArticle;2020;Kim, Hunmin et al., 2020;"Kim, Hunmin; Yoo, Sooyoung; Jeon, Yonghoon; Yi, Soyoung; Kim, Seok; Choi, Sun Ah; Hwang, Hee; Kim, Ki Joong";Characterization of Anti-seizure Medication Treatment Pathways in Pediatric Epilepsy Using the Electronic Health Record-Based Common Data Model.;Frontiers in neurology;;1664-2295;10.3389/fneur.2020.00409;usage;study;2020;409;;11;Front Neurol;med;Journal Paper;South Korea;single-country;SNUBH;May 2003 through October 2017;"Pediatric Epilepsy - Medication Treatment pathways, Pathways sind relevant zu identifzieren, weil nicht alle Massnahmen zum ""Anti-seizure"" in Form von Langzeitmedikamenten helfen";yes;no;no;< = 18 years;no;no;yes;"ANTIEPILEPTICS (concept_id = 
21604390, ATC L3), clobazam (concept_id = 19050832, RxNorm ingredient)";no;no;no;no;no;no;
11;969RW8T2;journalArticle;2020;Chandler, Rebecca E. et al., 2020;Chandler, Rebecca E.;Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug  reactions, and observational data from large health-care databases.;Pharmacoepidemiology and drug safety;;1099-1557 1053-8569;10.1002/pds.5022;usage;study;2020-08;951-957;8;29;Pharmacoepidemiol Drug Saf;med;Journal Paper;Sweden;single-country;VigiBase, several US Claim databases, no more details;;"Assessment of safety signals for ischemic colitis.. 
Ist an sich keine echte OHDSI Studie, die haben nur verschiedene Datenbanken und Literatur zu dem fachlichen Thema durchsucht und AE die reported wurden ausgewertet  ";yes;no;no;no;no;no;yes;"Nintedanib (S)
Prednisolone (S)
Acetylcysteine (C) 
Dimemorfan (C) 
Drug not accepted in WHODrug (C)
Vonoprazan (C)
Irbesartan; Trichlormethiazide (C)
Atorvastatin (C) 
Acetylsalicylic acid (C)
Alfacalcidol (C)
Levothyroxine (C)
Ascorbic acid; pantothenic acid (C)
Minodronic acid (C)
Insulin (C)
Tacrolimus (C)
Prednisolone (C)
Trimethoprim/sulfamethaxazole (C)
Warfarin (C)
Rabeprazole (C)
Loperamide (C)
Omeprazole (S)
Indacaterol (C)
Olmesartan (C)
Salbutamol (C)
Lercanidipine (C)
Docetaxel (S)
Zoledronic acid (C)
Levothyroxine (C)
Lansoprazole (C)
pratropium (C)
Glyceryl trinitrate (C)
Fluvastatin (C) 
Torasemide (C) 
Lormetazepam (C) 
Metamizole (C) 
Omeprazole (C)";no;no;no;no;no;no;
13;MLJYDR2F;journalArticle;2020;Choi, Youn I. et al., 2020;"Choi, Youn I.; Kim, Yoon Jae; Chung, Jun-Won; Kim, Kyoung Oh; Kim, Hakki; Park, Rae Woong; Park, Dong Kyun";Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study.;JMIR medical informatics;;2291-9694;10.2196/15124;usage;study;15.04.20;e15124;4;8;JMIR Med Inform;mi;Journal Paper;South Korea;single-country;K-CDM; January 1, 2006, to December 31, 2016;"Patienten mit entzündlichen Darmerkrankungen, 
Analyze des Effekts des Alters bei der Diagnose";yes;no;yes;>= 16 years;no;no;yes;Systemic steroid, biologic agent;no;no;no;no;no;no;
14;KA4LCF9M;journalArticle;2021;Jensen, Elizabeth T. et al., 2021;"Jensen, Elizabeth T.; Dabelea, Dana A.; Praveen, Pradeep A.; Amutha, Anandakumar; Hockett, Christine W.; Isom, Scott P.; Ong, Toan C.; Mohan, Viswanathan; D'Agostino, Ralph Jr; Kahn, Michael G.; Hamman, Richard F.; Wadwa, Paul; Dolan, Lawrence; Lawrence, Jean M.; Madhu, S. V.; Chhokar, Reshmi; Goel, Komal; Tandon, Nikhil; Mayer-Davis, Elizabeth";Comparison of the incidence of diabetes in United States and Indian youth: An international harmonization of youth diabetes registries.;Pediatric diabetes;;1399-5448 1399-543X;10.1111/pedi.13009;usage;study;2021-02;Aug 14;1;22;Pediatr Diabetes;med;Journal Paper;US;multi-country;SEARCH, YDR; 2006–2012 (YDR) and 2006, 2008, 2012 (SEARCH);Vergleich von Inzidence Raten bei Kinder/Jugendlichen von Diabetes zwischn Indien und USA unter Verwendung von Registry Daten;yes;no;no;< 20 years;no;no;no;;no;no;no;no;no;no;
15;BEWYM9BI;journalArticle;2020;Hripcsak, George et al., 2020;"Hripcsak, George; Suchard, Marc A.; Shea, Steven; Chen, RuiJun; You, Seng Chan; Pratt, Nicole; Madigan, David; Krumholz, Harlan M.; Ryan, Patrick B.; Schuemie, Martijn J.";Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension.;JAMA internal medicine;;2168-6114 2168-6106;10.1001/jamainternmed.2019.7454;usage;study;01.04.20;542-551;4;180;JAMA Intern Med;med;Journal Paper;US;single-country;CCAE, Clinformatics, OptumEHR;;Safety Outcomes der Behandlung von Hypertension durch Chlorthalidone vs Hydrochlorothiazide ;yes;yes;yes;no details;yes;yes;yes;"Acebutolol Aliskiren Amiloride Amlodipine Atenolol Azilsartan Benazepril Betaxolol Bisoprolol Bumetanide Candesartan Captopril Carvedilol Chlorthalidone Clonidine Diltiazem Doxazosin Enalapril Eplerenone Eprosartan
Felodipine Fosinopril Furosemide Guanfacine Hydralazine Hydrochlorothiazide Indapamide Irbesartan Isradipine
Labetalol Lisinopril Losartan Methyldopa Metolazone Metoprolol Minoxidil Moexipril Nadolol Nebivolol
Nicardipine Nifedipine Nisoldipine Olmesartan Penbutolol Perindopril Pindolol Prazosin Propranolol Quinapril Ramipril Spironolactone Telmisartan Terazosin Torsemide Trandolapril Triamterene Valsartan Verapamil";no;no;yes;https://cdn.jamanetwork.com/ama/content_public/journal/intemed/938433/ioi190117supp1_prod.pdf?Expires=1677987206&Signature=hP7~Y40l24tfjIYX-Rm9hmCmRWhbexNyHuSSaTfK2Qoccx-m3Uq9Xrb1H8o69urCaHLM7tSHbfRCdpr3DJqUzj4nTI15YzQbIskfySQQ9Co-wMOhs5AhPQis9Xj0Ng~lLcJZFO1rt1X8IpnvLsRM1uq9UK8q~zJiRrFQhyht6BfwFjiEoDzBgwWEB-Y5F31zpjNkCEEAgzIqzNXjxT~5zGT8NRFh30~hXDLiWG6AjOb1PavywgNFUuG4eC4Hg-kwvd3Na7w6BnRkqSvH9xbpozqoIvs5cRAl4lx0LoY2Lv32~RlsDM2IYabXq6Jo~ZismI3Yop57BgkK2AeiVuXq0w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA;yes;https://cdn.jamanetwork.com/ama/content_public/journal/intemed/938433/ioi190117supp1_prod.pdf?Expires=1677987206&Signature=hP7~Y40l24tfjIYX-Rm9hmCmRWhbexNyHuSSaTfK2Qoccx-m3Uq9Xrb1H8o69urCaHLM7tSHbfRCdpr3DJqUzj4nTI15YzQbIskfySQQ9Co-wMOhs5AhPQis9Xj0Ng~lLcJZFO1rt1X8IpnvLsRM1uq9UK8q~zJiRrFQhyht6BfwFjiEoDzBgwWEB-Y5F31zpjNkCEEAgzIqzNXjxT~5zGT8NRFh30~hXDLiWG6AjOb1PavywgNFUuG4eC4Hg-kwvd3Na7w6BnRkqSvH9xbpozqoIvs5cRAl4lx0LoY2Lv32~RlsDM2IYabXq6Jo~ZismI3Yop57BgkK2AeiVuXq0w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA;
16;CKF8QTC8;journalArticle;2021;Amutha, Anandakumar et al., 2021;"Amutha, Anandakumar; Praveen, Pradeep A.; Hockett, Christine W.; Ong, Toan C.; Jensen, Elizabeth T.; Isom, Scott P.; D'Agostino, Ralph B. Jr; Hamman, Richard F.; Mayer-Davis, Elizabeth J.; Wadwa, Raj Paul; Lawrence, Jean M.; Pihoker, Catherine; Kahn, Michael G.; Dabelea, Dana; Tandon, Nikhil; Mohan, Viswanathan";Treatment regimens and glycosylated hemoglobin levels in youth with Type 1 and Type 2 diabetes: Data from SEARCH (United States) and YDR (India) registries.;Pediatric diabetes;;1399-5448 1399-543X;10.1111/pedi.13004;usage;study;2021-02;31-39;1;22;Pediatr Diabetes;med;Journal Paper;India;multi-country;SEARCH, YDR;"  2006–2012 (YDR) and 2006, 
2008, 2012 (SEARCH)";Pediatrics T1 and 2 Diabetes - Treatment regimes + glycoslated hemogoblin (A1c) levels;yes;no;yes;< 20 years;no;no;yes;"metformin only (SEARCH = metformin only; YDR = biguanides); other oral hypoglycemic agents (OHAs) (which also included two or more OHAs) (SEARCH = other oral; YDR = sulphonylureas, glitazones, alpha glucosidase inhibitor, meglitinide analogues or DPP-4 inhibitor); insulin only (SEARCH = insulin only; YDR = regular, intermediate acting, premixed, long acting analogue, short acting analogue and premixed analogue); insulin + any OHAs (including metformin) (SEARCH = insulin + metformin or insulin + other oral; YDR = any insulin and any oral)";number of doses per day for insuline (twice, multible times);no;no;no;no;no;
17;5QTGJRAP;journalArticle;2020;Chen, Ruijun et al., 2020;"Chen, Ruijun; Ryan, Patrick; Natarajan, Karthik; Falconer, Thomas; Crew, Katherine D.; Reich, Christian G.; Vashisht, Rohit; Randhawa, Gurvaneet; Shah, Nigam H.; Hripcsak, George";Treatment Patterns for Chronic Comorbid Conditions in Patients With Cancer Using a Large-Scale Observational Data Network.;JCO clinical cancer informatics;;2473-4276;10.1200/CCI.19.00107;usage;study;2020-03;171-183;;4;JCO Clin Cancer Inform;med;Journal Paper;US;single-country;CUIMC, CCAE, MDCR, MDCD, Clinformatics, DAGermany, IQVIAFrance, STARR-OMOP;no information ;"Cancer patients -> characterization prevalence and distribution of treatmant patterns, for depressen, hypertension, T2 diabetes
data sources with 295,529,655 patients";yes;no;no;no details;no;no;yes;"ATC class L2 A10-drugs (drugs used in diabetes), ATC L3 A10X
ATC L2 C02 (antihypertensives), C03 (diuretics), C04 (vasodilators), C07 (beta blocking agents), C08 (calcium channel blockers), C09 (agents acting on renin-angiotensin system)
ATC L3 N06A (antidepressants) and N06AX (other antidepressants)
";no;no;no;no;no (referenced in paper under number 31, but link did not work);no;
18;AJ4ZR7JJ;journalArticle;2020;Spotnitz, Matthew E. et al., 2020;"Spotnitz, Matthew E.; Natarajan, Karthik; Ryan, Patrick B.; Westhoff, Carolyn L.";Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.;Obstetrics and gynecology;;1873-233X 0029-7844;10.1097/AOG.0000000000003656;usage;study;2020-02;319-327;2;135;Obstet Gynecol;med;Journal Paper;US;single-country;CUIMC;;Studie zum relativen Risiko der Erkankung an Gebärmutterhals Neoplasmen für Nutzerinnen der hormonfreien versus der Hormonspirale;yes;yes;no;<= 45 years, female;no;no;yes;Levonorgetrel, branded drug RxNorm Code 807283 (concept_id = 19132304);als branded drug RxNorm code schon;no;no;no;no;no;
19;2YQHJGYT;journalArticle;2020;Seo, Seung In et al., 2020;"Seo, Seung In; You, Seng Chan; Park, Chan Hyuk; Kim, Tae Joon; Ko, You Sang; Kim, Yerim; Yoo, Jong Jin; Kim, Jinseob; Shin, Woon Geon";Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common  data model.;Journal of gastroenterology and hepatology;;1440-1746 0815-9319;10.1111/jgh.14983;usage;study;2020-08;1325-1330;8;35;J Gastroenterol Hepatol;med;Journal Paper;South Korea;single-country;KD-CDM;January 1,2004 and December 31, 2018;;yes;no;no;>= 18 years (age);no;yes;yes;"
PPI: omeprazole,pantoprazole, lansoprazole, rabeprazole, omeprazole, ilaprazole, anddexlansoprazole

histamine-2 receptor antagonists (H2RA): im Paper nicht detailierter erwähnt, aber hier gefunden (https://www.ncbi.nlm.nih.gov/books/NBK547929/), diese 4 Typen: Cimetidine, Famotidine, Nizatidine, Ranitidine


Aspirin, Clopidogrel, NSAIDs, 
Cephalosporin, Quinolone,  Penicillin, Macrolide, Metronidazole, Steroid, Bisphosphonate, Probiotics

im paper waren die Medikamente als ""Medication history"" vermerkt";no;no;no;no;no;no;
20;PEYM4LQX;journalArticle;2021;Hockett, Christine W. et al., 2021;"Hockett, Christine W.; Praveen, Pradeep A.; Ong, Toan C.; Amutha, Anandakumar; Isom, Scott P.; Jensen, Elizabeth T.; D'Agostino, Ralph B. Jr; Hamman, Richard F.; Mayer-Davis, Elizabeth J.; Lawrence, Jean M.; Pihoker, Catherine; Kahn, Michael G.; Mohan, Viswanathan; Tandon, Nikhil; Dabelea, Dana";Clinical profile at diagnosis with youth-onset type 1 and type 2 diabetes in two pediatric diabetes registries: SEARCH (United States) and YDR (India).;Pediatric diabetes;;1399-5448 1399-543X;10.1111/pedi.12981;usage;study;2021-02;22-30;1;22;Pediatr Diabetes;med;Journal Paper;US;multi-country;SEARCH, YDR;2006 - 2012;diagnoesen T1 und T2 Diabetes;yes;no;yes;<= 20 years;yes;no;no;;no;no;no;no;no;;
21;HIDRHVBQ;journalArticle;2020;Brauer, Ruth et al., 2020;"Brauer, Ruth; Wong, Ian Chi Kei; Man, Kenneth Kc; Pratt, Nicole L.; Park, Rae Woong; Cho, Soo-Yeon; Li, Yu-Chuan Jack; Iqbal, Usman; Nguyen, Phung-Anh Alex; Schuemie, Martijn";Application of a Common Data Model (CDM) to rank the paediatric user and prescription prevalence of 15 different drug classes in South Korea, Hong Kong,  Taiwan, Japan and Australia: an observational, descriptive study.;BMJ open;;2044-6055;10.1136/bmjopen-2019-032426;usage;study;13.01.20;e032426;1;10;BMJ Open;med;Journal Paper;UK;multi-country;"AUSOM
CDARS
JMDC
NHIRD
PBS";January 2009 until December 2013;;no;no;no;< = 18 years;no;no;yes;"15 drug classes: Analgesics (including NSAIDs), Antibiotics, Adrenergics, Antihistamines, Mucolytics, Corticosteroids, Anti-infectives (excluding antibiotics and vaccines), Antiepileptics, Diuretics, Anticlotting and antifibrinolytic agents, Antidiabetic drugs, Psychotherapeutic agents, Antineoplastic and immunomodulating agents, Central nervous system stimulants, Contraceptives

alle Wirkstoffe als RxNorm/ATC können hier in dem Git Repo gefunden werden: https://github.com/OHDSI/StudyProtocols/blob/master/DrugsInPeds/inst/csv/CustomClassification.csv";no;no;yes;https://github.com/OHDSI/StudyProtocols/tree/master/DrugsInPeds;yes;https://github.com/OHDSI/StudyProtocols/tree/master/DrugsInPeds;
22;Q28AF5JR;conferencePaper;2019;Viernes, Benjamin et al., 2019;"Viernes, Benjamin; Lynch, Kristine E.; South, Brett; Coronado, Gregorio; DuVall, Scott L.";Characterizing VA Users with the OMOP Common Data Model.;Studies in health technology and informatics;;;10.3233/SHTI190561;usage;study;21.08.19;1614-1615;;264;;mi;Conference Paper;US;single-country;VA;2000 - 2017;"paper was a cohort characteristic of all patients available 
in the VA database, ten most common RxNorm drug ingredients reported in the paper";yes;no;no;>= 18 years (age);no;no;yes;"Acetaminophen, Simvastatin, 
Lisinopril, Omeprazole, Hydrocodone, Hydrochlorothiazide,  Ibuprofen, Amoxicillin, Aspirin, Naproxen";no;no;no;no;no;;
23;RKRTRIUY;journalArticle;2018;Kubota, Kiyoshi et al., 2018;"Kubota, Kiyoshi; Kamijima, Yukari; Kao Yang, Yea-Huei; Kimura, Shinya; Chia-Cheng Lai, Edward; Man, Kenneth K. C.; Ryan, Patrick; Schuemie, Martijn; Stang, Paul; Su, Chien-Chou; Wong, Ian C. K.; Zhang, Yinghong; Setoguchi, Soko";Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study.;PloS one;;1932-6203;10.1371/journal.pone.0208796;usage;study;2018;e0208796;12;13;PLoS One;mi;Journal Paper;Japan;multi-country;NHIRD, CDARS, JMDC, MDCR (5% radnom sample);2001 - 2014 ;;yes;no;no;no details;no;no;yes;"Alpha-glucosidase inhibitor
Biguanide
DPP-4 inhibitor
Insulin
Meglitinide
Sulfonylurea
Thiazolidinedione, 
Antiarrhythmic
Antidementia
Antidepressant
Anti-Parkinson
Antipsychotic
Benzodiazepine
-Blocker
Calcium channel blocker
COPD medication
Diuretic
Non-statin lipid-lowering
drug
NSAID
RAS inhibitor
Statin	
Vitamin K antagonist";no;no;no;no;no;;
24;2HWTYLTS;journalArticle;2018; Zhang, Xin et al., 2018;"Zhang, Xin; Wang, Li; Miao, Shumei; Xu, Hua; Yin, Yuechuchu; Zhu, Yueshi; Dai, Zuolei; Shan, Tao; Jing, Shenqi; Wang, Jian; Zhang, Xiaoliang; Huang, Zhongqiu; Wang, Zhongmin; Guo, Jianjun; Liu, Yun";Analysis of treatment pathways for three chronic diseases using OMOP CDM.;Journal of medical systems;;1573-689X 0148-5598;10.1007/s10916-018-1076-5;usage;study;13.11.18;260;12;42;J Med Syst;med;Journal Paper;China;single-country;Nanjing;2005 - 2015;;yes;no;no;no details;no;no;yes;Acarbose, Insulin, Insulin. Glargine. Human, Repaglinide, Metformin, Phenformin, Gliclazide, Glipizide, Insulin Aspart. Human, Gimerpiride, Gliquidone, Glyburide, Insulin. Lispro. Human, Sitagliptin, Nateglinide, Pioglitazone, Insulin. Protamine Zinc. Beef_Pork, Rosiglitazone, Saagliptin, Vildagliptin, Benazepril Fosinopril, Amlodipine, Indapamide, Valsartan, Felodipine, Carvedilol, Irbesartan, Losartan, Imidapril, Perindopril, Olmesartan, Captopril, Cliazapril, Dihydralazine, Urapidil, Telmisartan, Lercanidipine, reserpine, Lacidipine, Candesartan, Lisinopril, Doxazosin, Rampipril, Nitroprusside, Trazodone, Citalopram, Sertaline, Mirtazapine, Fluoxetine, Paroxetine, Venlafaxine, Fluvoxamine, Duloxetine ;no;no;no;no;no;no;
25;WJRLZFNB;journalArticle;2018;Vashisht, Rohit et al., 2018;"Vashisht, Rohit; Jung, Kenneth; Schuler, Alejandro; Banda, Juan M.; Park, Rae Woong; Jin, Sanghyung; Li, Li; Dudley, Joel T.; Johnson, Kipp W.; Shervey, Mark M.; Xu, Hua; Wu, Yonghui; Natrajan, Karthik; Hripcsak, George; Jin, Peng; Van Zandt, Mui; Reckard, Anthony; Reich, Christian G.; Weaver, James; Schuemie, Martijn J.; Ryan, Patrick B.; Callahan, Alison; Shah, Nigam H.";Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With  Metformin: Analysis From the Observational Health Data Sciences and Informatics  Initiative.;JAMA network open;;2574-3805;10.1001/jamanetworkopen.2018.1755;usage;study;03.08.18;e181755;4;1;JAMA Netw Open;med;Journal Paper;US;multi-country;CCAE, CUIMC, IQVIAFrance, MDCR, Clinformatics, Mt Sinai, AUSOM, STARR-OMOP;246 558 805 patients;;yes;yes;yes;no details;no;no;yes;sulfonylureas, DPP-4 inhibitors, thiazolidinediones, metformin;no;no;no, concepts in supplement file only https://cdn.jamanetwork.com/ama/content_public/journal/jamanetworkopen/937417/zoi180106supp1_prod.pdf?Expires=1678641942&Signature=I1M~35jmMCLI3C-~GZIXoPnNnjAspV9Q4JMkbCfgB9v79TvNk1d7d9Xe6UfSEPt5b4m5SljUrkbA3juDaGf124506kW5DGJNBIGQRMyYRDVN1nqvxHrtCWYVrXOVsWCZ2pwPF15idK7hMTHJxbOfb3xpFkQQNZoOnL994Hhp2zxO9XiDwt8OJJDEDngOQKdQxmrExm2LxB~WaOGmPthMK8-4ps6ny86IjsxB-DNUegPBdB34QjQGYjsApmKHDfn8zSCrgKgTsaNDNJ4G0JbUHQHC35kIf1Nv3Ytckl81PFjEO77EVhCCkkyaN4qNMxxwzD1dRLbeqz42iDj8uvKg-A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA;no;no;no;
26;JL54MENY;journalArticle;2018; Boland, Mary Regina et al., 2018;"Boland, Mary Regina; Parhi, Pradipta; Li, Li; Miotto, Riccardo; Carroll, Robert; Iqbal, Usman; Nguyen, Phung-Anh Alex; Schuemie, Martijn; You, Seng Chan; Smith, Donahue; Mooney, Sean; Ryan, Patrick; Li, Yu-Chuan Jack; Park, Rae Woong; Denny, Josh; Dudley, Joel T.; Hripcsak, George; Gentine, Pierre; Tatonetti, Nicholas P.";Uncovering exposures responsible for birth season - disease effects: a global study.;Journal of the American Medical Informatics Association : JAMIA;;1527-974X 1067-5027;10.1093/jamia/ocx105;usage;study;01.03.18;275-288;3;25;J Am Med Inform Assoc;med;Journal Paper;US;"single-country -> 
multi-country (corrected)";"NHIRD, AUSOM, Mt Sinai, CUIMC, Vander
Wash";;es geht hier um Umweltfaktoren, die einen Einfluss auf  die Geburt und den Zeitpunkt nehmen können;yes;no;no;women only ;yes;no;no;no;no;no;no;no;no;no;
27;2STKFIEN;journalArticle;2017;Duke, Jon D. et al., 2017;"Duke, Jon D.; Ryan, Patrick B.; Suchard, Marc A.; Hripcsak, George; Jin, Peng; Reich, Christian; Schwalm, Marie-Sophie; Khoma, Yuriy; Wu, Yonghui; Xu, Hua; Shah, Nigam H.; Banda, Juan M.; Schuemie, Martijn J.";Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network.;Epilepsia;;1528-1167 0013-9580;10.1111/epi.13828;usage;study;2017-08;e101-e106;8;58;Epilepsia;med;Journal Paper;US;"single-country -> 
multi-country (corrected)";CUIMC, AmbEMR, IQVIA France, STARR-OMOP, Clinformatics, CCAE, MDCD, MDCR, P-Plus, UTCHF;;;yes;no;no;no details;no;no;yes;levetiracetam, Phenytoin;no;no;no;no;no;no;
28;6R68RGZD;journalArticle;2016;Samwald, Matthias et al., 2016;"Samwald, Matthias; Xu, Hong; Blagec, Kathrin; Empey, Philip E.; Malone, Daniel C.; Ahmed, Seid Mussa; Ryan, Patrick; Hofer, Sebastian; Boyce, Richard D.";Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.;PloS one;;1932-6203;10.1371/journal.pone.0164972;usage;study;2016;e0164972;10;11;PLoS One;mi;Journal Paper;US;single-country;CCAE, MDCR, MDCD;1/1/2009–12/31/2012;;no;no;no;no details;no;no;yes;"amitriptyline, azathioprine, 
clomipramine, clopidogrel, doxepin, glimepiride, haloperidol, imipramine, mercaptopurine, metoprolol, nortriptyline, paroxetine, propafenone, risperidone sertraline, tamoxifen, thioguanine, tramadol, venlafaxine";no;no;no;no;no;no;
29;IJC9TVI9;conferencePaper;2016;Hripcsak, George et al., 2016;"Hripcsak, George; Ryan, Patrick B.; Duke, Jon D.; Shah, Nigam H.; Park, Rae Woong; Huser, Vojtech; Suchard, Marc A.; Schuemie, Martijn J.; DeFalco, Frank J.; Perotte, Adler; Banda, Juan M.; Reich, Christian G.; Schilling, Lisa M.; Matheny, Michael E.; Meeker, Daniella; Pratt, Nicole; Madigan, David";Characterizing treatment pathways at scale using the OHDSI network;PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA;;;10.1073/pnas.1510502113;usage;study;05.07.16;7329-7336;;113;;med;COLLOQUIUM PAPER;US;single-country;"AUSOM, CCAE, CPRD, CUIMC, GE, INPC, 
JMDC, MDCD, MDCR, Clinformatics, STARR-OMOP";;;yes;no;no;>= 18 years (age);no;no;yes;"medication with T2 diabetes: 
Metformin, Gliclazide, pioglitazone, sitagliptin, glimepiride, Glipizide, rosiglitazone, Glyburide, Insulin (Glargine, Human), exenatide, liraglutide, Insulin (Aspart, Human), saxagliptin
medication with Hypertension: Hydrochlorothiazide, Lisinopril, Metoprolol, Amlodipine, Furosemide, Losartan, Atenolol, Valsartan, Carvedilol, Triamterene, Diltiazem, Ramipril, Benazepril, Olmesartan, Spironolactone, Clonidine
medication with Depression: Citalopram, Bupropion, Sertaline, Escitalopram, Fluoxetine, Trazodone, Venlafaxine, Duloxetine, Paroxetine, Amitriptyline, Mirtazapine, Desvenlafaxine, Nortriptyline, Doxepin";no;no;no;no;no;no;